As Colorado becomes one of the nation’s first states to legalize psilocybin, researchers are studying whether the drug, combined with therapy, can help people with major depression. Our conversation with Scott Thompson, a neuroscientist at the University of Colorado School of Medicine, is part our series, “The Trip," a CPR News series on Colorado’s new psychedelic movement. Thompson, who also directs the Psychedelic Public Policy Partnership, which has advised the state on the new psilocybin law, also discusses the potential benefits of the drug for conditions like bipolar disorder and alcoholism.
Here's more information about the study on depression, including criteria for people interested in participating.
